1. |
Furuse M, Fujita K, Hiiragi T, et al. Claudin-1 and -2:novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin[J]. J Cell Biol, 1998, 141(7):1539-1550.
|
2. |
Schneeberger EE, Lynch RD. The tight junction:a multifunctional complex[J]. Am J Physiol Cell Physiol, 2004, 286(6):C1213-C1228.
|
3. |
English DP, Santin AD. Claudins overexpression in ovarian cancer:potential targets for Clostridium Perfringens Enterotoxin (CPE) based diagnosis and therapy[J]. Int J Mol Sci, 2013, 14(5):10412-10437.
|
4. |
Günzel D, Yu AS. Claudins and the modulation of tight junction permeability[J]. Physiol Rev, 2013, 93(2):525-569.
|
5. |
Ionescu Popescu C, Liliac L, Ceauşu RA, et al. CLDN3 expression and significance-breast carcinoma versus ovarian carcinoma[J]. Rom J Morphol Embryol, 2013, 54(1):99-106.
|
6. |
Twiss F, Oldenkamp M, Hiemstra A, et al. HGF signaling regulates Claudin-3 dynamics through its C-terminal tyrosine residues[J]. Tissue Barriers, 2013, 1(4):e27425.
|
7. |
Mccole DF. Phosphatase regulation of intercellular junctions[J]. Tissue Barriers, 2013, 1(5):e26713.
|
8. |
Guntaka SR, Samak G, Seth A, et al. Epidermal growth factor protects the apical junctional complexes from hydrogen peroxide in bile duct epithelium[J]. Lab Invest, 2011, 91(9):1396-1409.
|
9. |
Ogawa M, Kojima T, Someya M, et al. Epidermal growth factor modulates claudins and tight junctional functions in ovarian cancer cell lines[J]. Histochem Cell Biol, 2012, 138(2):323-338.
|
10. |
Yamauchi K, Rai T, Kobayashi K, et al. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins[J]. Proc Natl Acad Sci USA, 2004, 101(13):4690-4694.
|
11. |
Pan XY, Wang B, Che YC, et al. Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue[J]. Int J Gynecol Cancer, 2007, 17(1):233-241.
|
12. |
Kobayashi K, Oyama S, Numata A, et al. Lipopolysaccharide disrupts the milk-blood barrier by modulating claudins in mammary alveolar tight junctions[J]. PLoS One, 2013, 8(4):e62187.
|
13. |
Kwon MJ, Kim SS, Choi YL, et al. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications[J]. Carcinogenesis, 2010, 31(6):974-983.
|
14. |
Casagrande F, Cocco E, Bellone S, et al. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin[J]. Cancer, 2011, 117(24):5519-5528.
|
15. |
Yoshida H, Sumi T, Zhi X, et al. Claudin-4:a potential therapeutic target in chemotherapy-resistant ovarian cancer[J]. Anticancer Res, 2011, 31(4):1271-1277.
|
16. |
Huang YH, Bao Y, Peng W, et al. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis[J]. Proc Natl Acad Sci USA, 2009, 106(9):3426-3430.
|
17. |
Shang X, Lin X, Alvarez E, et al. Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases[J]. Neoplasia, 2012, 14(10):974-985.
|
18. |
Long H, Crean CD, Lee WH, et al. Expression of clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium[J]. Cancer Res, 2001, 61(21):7878-7881.
|
19. |
Sheehan GM, Kallakury BV, Sheehan CE, et al. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas[J]. Hum Pathol, 2007, 38(4):564-569.
|
20. |
Bartholow TL, Chandran UR, Becich MJ, et al. Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma[J]. Diagn Pathol, 2011, 6:12.
|
21. |
郭振营,马军. Claudin-1、Claudin-3在胃癌组织中的表达及意义[J]. 山东医药, 2009, 49(1):55-56.
|
22. |
Oliveira SS, Morgado-Díaz JA. Claudins:multifunctional players in epithelial tight junctions and their role in cancer[J]. Cell Mol Life Sci, 2007, 64(1):17-28.
|
23. |
De Souza WF, Fortunato-Miranda N, Robbs BK, et al. Claudin-3 overexpression increases the malignant potential of colorectal cancer cells:roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling[J]. PLoS One, 2013, 8(9):e74994.
|
24. |
Montgomery E, Mamelak AJ, Gibson M, et al. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions[J]. Appl Immunohistochem Mol Morphol, 2006, 14(1):24-30.
|
25. |
韩凤艳, 刘爱东. 喉鳞癌组织中Claudin-3和E-cad表达的临床意 义[J]. 中国老年学杂志, 2011, 31(2):202-203.
|
26. |
Soini Y. Expression of claudins l, 2, 3, 4, 5 and 7 in various types of tumours[J]. Histopathology, 2005, 46(5):551-560.
|
27. |
李娟, 涂媛, 蒋莉莉, 等. Snail和Claudin-3在非小细胞肺癌中的表达及意义[J]. 中国肺癌杂志, 2012(10):583-590.
|
28. |
Yuan X, Lin X, Manorek G, et al. Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors[J]. Mol Cancer Ther, 2009, 8(7):1906-1915.
|
29. |
Takahashi A, Kondoh M, Yagi K. Non-invasive drug delivery system with the claudin binder[J]. Yakugaku Zasshi, 2011, 131(11):1583-1587.
|